Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arctic Bioscience Director's Dealing 2021

Feb 26, 2021

3536_dirs_2021-02-26_37b2a162-6100-4ee3-9a93-8192d69bcee4.html

Director's Dealing

Open in viewer

Opens in your device viewer

Mandatory Notification of Trade by Close Associate of Primary Insider

Mandatory Notification of Trade by Close Associate of Primary Insider

Ajea Invest AS, a company owned 100% by board member in Arctic Bioscience AS, Asbjørn Solevågseide, has on 25 February 2021 acquired 17,500 shares in Arctic Bioscience AS. The shares were acquired at Euronext Growth Oslo at a price of NOK 28,4405 per share.

After this transaction, Ajea Invest AS holds 275,564 Shares in Arctic Bioscience AS directly, and 12.8% of the share capital in PIR IV Invest AS, which holds 2,188,250 Shares in the Company.